Driving Innovation and Consistency in ALS Trials: Collaborative Models, New Outcomes, and Smarter Study Design

• Elevating trial quality through harmonized SOP‑based training across 60 European sites.
• Advancing TRICALS outcome measures and prediction models to include broader patient populations.
• Strengthening industry–academic collaboration to streamline innovation without duplicating efforts.
• Key insights from annual pharma masterclasses on emerging challenges in ALS trial design.

Speakers:

Leonard van den Berg

Professor of Neurology, Neurologist & Chairman of TRICALS

UMC Utrecht